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Nanotechnology industry focuses primarily on promoting nanoscience as a “green” technology to provide a way for 
less-toxic environmentally benign economic expansion and to synthesize eco- friendly and innocuous drugs to cater to the 
needs of the contemporary world. An attempt has been made to prepare silver, gold and copper nanoparticles using the 
aqueous flower extract of Azhadiracta indica (neem).  In-vitro anti-oxidant efficacy of these metal nanoparticles (NPs) were 
investigated through  i) Hydrogen atom transfer (HAT) reaction based assays- (ABTS scavenging effect and Hydroxyl 
radical scavenging effect) and ii)  Electron transfer (ET) reaction based assays(DPPH radical scavenging activity and NO 
free radical scavenging activity). CuNPs exhibits better activity compared to AgNPs and AuNPs. In vitro anti-diabetic test 
was conducted for all the three NPs through three methods namely inhibition of α- glucosidase enzyme assay, inhibition of 
alpha amylase enzyme assay and Non-enzymatic glycosylation of hemoglobin assay. CuNPs had a remarkable anti-diabetic 
activity which was close to the standard acarbose. 
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Nanomaterials have evolved as one of the most 
promising field in the research for improved 
antioxidants. Diverse nanomaterials, including 
possessing inherent anti-oxidant, anti-microbial and 
cytotoxic properties, which depend on their surface 
properties, and not on their functionalization, have 
been reported1-7. Reactive oxygen species (ROS) viz., 
single oxygen, peroxynitrite, hydrogen peroxide, 
superoxide and hydroxyl radical are the normal 
byproducts of cellular breath that can cause cellular 
disintegration by oxidation process8. A better 
understanding of new nanoparticles with enhanced 
properties, as well as their combination into a unique 
form with enhanced antioxidant properties, will shape 
up the future of nano antioxidant-mediated 
treatments9. Although a wide spectrum of synthetic 
drugs are being used recently. Many drugs had 
disturbing side effects such as colic, borborygmus and 
diarrhoea10-12. Several researchers have attempted to 
identify alternative anti-diabetic compounds involving 
metal ions such as V3+, Zn+2, Mn+2, Cu+2, Cr+3, and 
W+6 13-20. Synthesis of metal nanoparticles through 
ecofriendly green route are more effective and 
efficient21. An elaborate description of the synthesis 
of different metal nanoparticles through 
environmentally benign green route is reported22. 
Early reports have highlighted the importance of 
metal nanoparticles synthesized through non-toxic 
environmentally benign green conditions, which is of 
crucial importance to address the growing needs on 
the overall toxicity of metallic nanoparticles (MNPs) 
for medical and technological applications23. Among 
these silver (AgNPs), have been studied extensively24-
26. Fabrication of CuNPs using plant metabolites were
investigated at length27. Azhadirachta indica (Neem)
plant is one of the most studied medicinal plants, the
different parts of which is explored by researchers and
whose anti-diabetic activity and anti-oxidant activity
is well established28. The flowers of this plant possess
wide variety of phytochemicals. The GC analysis of
methanolic and n-hexane extracts of neem
flower, reveals the presence of many important
phytochemicals29. The green aqueous extraction of the
phytochemicals present in neem flower, ( called
Neem flower Aqueous Extract, NFAE) and the
syntheses of silver, gold , copper nanoparticles using
this extract, (AgNPs, AuNPs and CuNPs, collectively
referred as NFAE-MNPs ), which was the authors’ novel
attempt, has been reported by the authors earlier 30-32. The
objective of the current study is to investigate
he anti–oxidant and anti-diabetic efficacy of
NFAE-MNPs.





Chemicals and reagents 
Chemicals utilized were procured from Sigma-
Aldrich and used as received. 
 
Preparation of neem flower aqueous extract (NFAE) 
Azhadirachta indica flowers were collected, 
between the months of March and July, dried under 
sunshade for seven days and made into fine powder. 
About 500 g of this powder was macerated, boiled in 
500 mL deionized water, maintaining a basic pH, for 
two hours. The solution was allowed to stand 
overnight, digested twice and filtered using a 
Whatmann No1 filter paper. The filtrate was 
immediately used for the synthesis of AgNPs, AuNPs 
and CuNPs. 
 
Preparation of electrolyte stock solutions and biosynthesis of 
metal nanoparticles (NFAE-MNPs) 
Stock solutions of AgNO3, HAuCl4 and CuSO4 
were prepared in the range of 0.1mM to  
2mM. Various specifications such as substrate 
concentration, measure of plant extract, pH and the 
variations in temperature were optimized using UV-
Vis spectroscopic method. The optimized conditions 
were used to synthesis all the three NFAE-MNPs 30-32. 
 
Characterization techniques 
The green synthesized MNPs were characterized 
utilizing the analytical instrument namely UV-Visible 
spectroscopy, FTIR spectroscopy, XRD measurements 




The in-vitro anti-oxidant activity of the green 
synthesized nanoparticles was studied through four 
methods which are classified under two headings as 
follows: 1. Electron transfer (ET) reaction based 
assays: DPPH Radical Scavenging Activity, NO free 
radical scavenging activity; 2.Hydrogen atom transfer 
(HAT) reaction based assays: ABTS scavenging 
effect, hydroxyl radical scavenging effect. 
 
Scavenging activity of 1, 1-diphenyl-2-picrylhydrazyl (DPPH) 
radical 
This important radical scavenging activity was 
executed in pursuant to the methodology reported 
amidst certain modifications33.s All the three NFAE-
MNPs were mixed with methanol and sonicated for 
two minutes. Thus the stock solution was prepared 
(10 mg/100mL) individually. From this stock solution 
different concentrations of 20μg/mL to 100μg/mL 
were taken in separate test tubes. A 0.004% (w/v) 
solution of DPPH in methanol, prepared afresh was 
added to each of these test tubes and vortexed 
thoroughly. After an elapse of 10 minute interval the 
decline in the absorbance was noted at 517 nm with the 
repeated procedure to get duplicate values. Ascorbic 
acid at the same concentration was used as the control. 
For the use of blank reagent methanol (95%) was used.  
Percentage of the DPPH free radical scavenged was 
tallied by adopting the following relation 
 
% scavenging= [(Abs control- Abstest sample) x 100] / Abs control 
 
Where, Abscontrol refers to the absorbance of DPPH + 
methanol and Abstestsample denotes the absorbance of 
DPPH + sample (NFAE-MNPs / standard). 
 
NO free radical scavenging assay 
This experiment was conducted for all the three 
NFAE-MNPs estimated according to the earlier 
described method with certain modifications34.  
A 5 mM saline solution of Sodium nitroprusside 
solution buffered using phosphate was mixed with 
diverse concentrations of NFAE-MNPs and nurtured 
at 25 C for 150 min. The samples were then vortexed 
with Griess reagent and the absorbance was observed 
at 546 nm. The positive control was ascorbic acid. 
The IC50 values for the standard besides each of the 
test sample were determined as follows, 
 
% scavenging = [(Abs control−Abs test sample)/Abs 
control] ×100 
 
AbsControl refers to the absorbance of the ABTS 
radical which together with methanol and Abs sample 
indicates the absorbance of the ABTS radical in 
conjunction with the sample (NFAE-MNPs or the 
standard). 
 
2, 2′-Azino-bis (3-ethylbenzthiazoline-6-sulfonic acid) (ABTS) 
radical scavenging assay 
This assessment was conducted for all the three 
NFAE-MNPs as described earlier with minor 
modifications34. 45μL of 0.138 M solution of 
potassium persulphate mixed with 3.88M ABTS 
solution and left in dark condition for 15 h at ambient 
temperature. A mixture of two solutions namely 1 mL 
of ABTS solution and 88 ml of 50% ethanol was 
considered as the working solution. 25 μL of various 
concentrations of NFAE-MNPs (20μg/mL to 




100μg/mL) were blended with 250 μL of ABTS 
working solution and the maximum absorbance was 
determined at 734 nm, with ascorbic acid as the 
standard. The study was done in duplicate and the 
percentage inhibition was calculated as follows.  
 
Inhibition (%) = [(Abs Control-Abs test sample) ×100] / Abs Control 
 
Abs Control is the absorbance of the ABTS radical 
including methanol and Abs test sample refers to the 
absorbance of the ABTS radical including the sample 
(NFAE-MNPs/standard). 
 
Hydroxyl radical scavenging assay 
The significant and most important assay, namely 
the OH radical scavenging activity, was ascertained 
according to the procedure described in earlier 
study34. 75 μL of each of the three NFAE-MNPs  
solution (20-100 μg/mL in methanol) was mixed with 
90 millimoles of sodium phosphate buffer solution, 
1.5 micromoles of deoxyribose, 1.5 micromoles of 
FeSO4 -EDTA , 1.5 millimoles of H2O2 and 525 μL 
deionized water. After an incubation time of one hour, 
at 37 C, process the reaction was interrupted through 
the inclusion of a mixture of 750μLof CCl3COOH 
(2.8%) and 750 μL of sodium thiobarbiturate(1% 
solution dissolved in 0.05M sodium hydroxide), 
boiled, cooled and was measured at 520 nm. The 
analysis was performed in duplicate with ascorbic 
acid as standard and methanol as blank. The extent of 
hydroxyl radical scavenging activity as the 
percentage, was evaluated using the relation 
 
% scavenged = (Abscontrol – Abs sample)/Abs control,  
 
In the above relation, Abscontrol indicates the 
absorbance of the control (all the reagent except the 
test sample) and Abssample refers to the absorbance of 
NFAE-MNPs/ ascorbic acid. 
 
Anti-diabetic assay 
All the three biosynthesized NFAE-MNPs were 
evaluated for their in-vitro anti-diabetic activity by the 
following three procedures. 
 
 Non Enzymatic Glycosylation of Hemoglobin Assay 
A modified procedure is adopted to estimate  
the extent of non-enzymatic glycosylation of 
hemoglobin35,36. 1g/L solutions of all the three NFAE-
MNPs and α-Tocopherol using DMSO were prepared. 
To the disparate concentrations obtained from stock 
solution (20-100μg/mL), Gentamycin (0.02% in 0.01 
M phosphate buffer) (1 mL), glucose solution  
(1 mL) and hemoglobin solution (1 mL) were added. 
After an incubation period of 72 h, in dark, the 
absorbance was read at 520 nm. The method to 
prepare the control was akin to the one stated earlier, 
omitting the addition of extract. The well-known 
pharmaceutical standard, α-Tocopherol was utilized in 
this measurement and the inhibition percentage was 
computed as follows 
 
Percentage of Inhibition = [(Abs sample – Abs control) × 
100] / Abs sample  
 
 Inhibition of α- glucosidase enzyme assay 
The scope of this measurement was observed by 
following the procedure already stated with minor 
modifications37. The assay mixture consist of 
15micromoles of sodium phosphate buffer (pH 7), 100 
μL of α -glucosidase, and test samples (standard/NFAE-
MNPs) were considered at five different concentrations 
of 20, 40, 60, 80 and 100 µg/mL in dimethyl sulphoxide. 
After the denouement of maintenance of 10 min, at  
37°C, 0.1 micromoles of paranitrophenyl α-D-
glucopyranoside dissolved in 100mM Na3PO4 buffer 
was combined with the mixture. This was followed by 
incubation for 20 min at 37°C and terminating the 
process by the addition of 50 micromoles of sodium 
carbonate solution followed by the measurement of 
absorbance at 405 nm. The outcome of the measurement 
was communicated as percentage of the blank control. 
The sample with α-glucosidase, and without NFAE-
MNPs, was considered as the control considering 100% 
enzyme activity. Acarbose performs the role of standard 
of reference. 
 
% Inhibition = (Acontrol– Asample)/Acontrol × 100  
 
Where Acontrol = absorbance without standard/NFAE-
MNPs; Asample = absorbance with standard/ NFAE-
MNPs. 
 
Inhibition of alpha amylase enzyme assay 
This measure was performed using dinitrosalicylic 
acid reagent (DNSA) as stated in literature38. The 
mixture which is to be investigated consists of 10 
micromoles of a buffer solution (prepared using 
Na2HPO4-7H2O and NaH2PO4H2O at pH 7), 100 μL 
of α-amylase solution and test samples 
(standard/NFAE-MNPs) at five different 
concentrations namely 20, 40, 60, 80 and 100 µg/mL 
in DMSO. After the culmination of an incubation time 
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of 20 min at 37°C, starch solution (containing 2.5mg 
starch prepared using the buffer), was added to the 
tubes and incubated for 15 min at 37°C.  Termination 
of the process was done by including DNSA (1 mL) 
followed by incubation for 10 min. The tubes were 
air-cooled to ambient temperature and were assessed 
at 540 nm. The sample which was considered as the 
reference constituted all other reagents and the 
enzyme barring the sample to be inspected. Acarbose 
was taken as the standard. The extent of inhibition 
was computed according to the ensuing relation, 
Percentage of inhibition = [(AI-540–AE-540)/AI-540] x100 
In the above relation, AI-540refers to absorbance 
determined without adding standard/NFAE-MNPs; 
AE-540indicates the absorbance achieved with 
standard/NFAE-MNPs 
Results and Discussion 
Various parameters such as the electrolyte 
concentration, the aqueous plant extract volume, pH 
of the medium and the reaction temperature play a 
significant role in the morphology and size in the 
NPs. All the three MNPs were synthesized after 
optimizing these conditions. The UV-Vis, FTIR, XRD 
and TEM results of all the three MNPs have been 
published by the authors’ earlier33-35. Each of the three 
MNPs synthesized shows the characteristic of SPR 
bands. The presence of organic moieties capped on 
the synthesized MNPs could be well understood from 
the FTIR spectrum of these NPs. While the XRD 
pattern of NFAE-AgNPs shows peaks at 2θ values 
38.1, 44.3, 64.5 and 77.4, that of NFAE-AuNPs 
had 2θ values indexed at 37.9, 44.2, 64.3 77.4 and 
that of the NFAE-CuNPs had peaks at 2θ values at 
43.5, 50.6and 74.3 revealing the FCC crystal 
system all these distinct diffraction peaks. The mean 
crystallite size was calculated using the Scherer’s 
formula, with 16.11nm, 38.48nm and 36.59nm for 
NFAE-AgNPs, NFAE-AuNPs and NFAE-CuNPs 
respectively. TEM results were in close correlation 
with these values. All the three green synthesized 
NFAE-MNPs were appraised for their free radical 
scavenging capacity and the evaluation was done in 
comparison to ascorbic acid as the standard. The 
results are shown in Fig. (1a, 1b, 2a, 2b) and the 
concentration required for 50% inhibition, (IC50), is 
shown in Table 1. The values of correlation 
coefficient, indicated as R, and the determination 
coefficient, indicated as R2, are also tabulated. 
Elevated values of R and R2 indicate the goodness of 
fit in these observations. 
DPPH radical is nitrogen centered, room 
temperature stable free radical, which is regularly 
used to assess the antioxidant activity of 
nanoparticles. The antioxidant activity of NFAE-
MNPs can be determined spectrophotometrically by 
monitoring the change in color of DPPH from violet 
to yellow. Towards DPPH radical, all the three NFAE-
MNPs showed increasing inhibitory activity as the 
concentration of the NFAE-MNPs were increased. 
Among the three nanoparticles, NFAE-CuNPs shows 
best results (Fig. 1a) as against the standard. A 
maximum inhibition of 78.72% is seen at a 
concentration of 100μg/mL. Though the IC50 value 
was nearly double as that of the standard, it was better 
than that reported40. NFAE-AuNPs exhibited a % 
activity intermediate between NFAE-AgNPs and 
Fig. 1 — Results of DPPH Radical Inhibition assay 




NFAE-CuNPs. It is suggested that the organic 
moieties present as the capping agent interacts 
differently on the basis of their structures, which 
results in different % of inhibition.NO radical 
scavenging ability of the nanoparticles are assessed 
using Griess reagent, which forms a coloured 
complex called form a zone. The % inhibition 
determined for NO radical scavenging assay is 
presented in Fig. 1b. As the concentration was 
increased beyond 40µg/mL, an abrupt  increase  in  
the% inhibition was observed, similar to that observed in  
DPPH assay, for all the NFAE-MNPs. the IC50 values 
(Table 1) is indicative of a better inhibitory ability 
towards NO than DPPH. Once again NFAE-CuNPs 
exhibited better NO radical inhibition, with a value of 
84.72% at 100μg/mL concentration. NFAE-AgNPs 
and NFAE-AuNPs reached a maximum inhibition of 
79.72% and 79.45% respectively. This sort of an 
increased inhibitory activity might be due to the 
presence of thiol groups in NFAE43.As the 
concentration of all the three test samples have 
increased, the ABTS cation radical scavenging 
activity also increased markedly. NFAE-CuNPs 
exhibits maximum inhibition of 88.72% as against the 
standard which shows 90.6%. The hydroxyl radical 
scavenging assay of all the three NFAE-MNPs 
showed very good activity, with NFAE-CuNPs 
showing the maximum inhibitory percentage of 
89.445. The IC50 values (Table 1) were also near the 
standard indicating the ability of the three test 
samples to behave as efficient anti-oxidants. The 
presence of a plethora of able binding and strongly 
interacting organic moieties and components on the 
expanse of the biosynthesized NFAE-MNPs, 
confirmed from their FTIR spectra31-33, in 
combination with particle size and other inherent 
properties are suggested to be the reasons for the anti-
oxidant behavior. In addition, the mechanism for the 
 
 
Fig. 2 — Results of NO Free Radical Inhibition assay 
Table 2 — Results obtained for all the three anti – diabetic assays performed for all the three NFAE-MNPs . 
IC50 , R and R
2 values are  compared with the control . 
Method  NFAE-AgNPs NFAE-AuNPs NFAE-CuNPs Control 
Non enzymatic glycosylation 
of Hemoglobin assay 
(control:  
α –Tocopherol) 
IC50 (μg/mL) 61.42 72.17 61.43 62.26 
R 0.989 0.982 0.993 0.997 
R2 0.980 0.965 0.987 0.996 
Inhibition of α- glucosidase 
enzyme assay 
(control : acarbose) 
IC50(µg/mL) 48.01 58.66 44.85 43.8 
R 0.974 0.996 0.987 0.975 
R2 0.9501 0.993 0.975 0.952 
Inhibition of alpha amylase 
enzyme assay 
(control : acarbose) 
IC50(µg/mL) 44.07 45.72 37.41 40.879 
R 0.961 0.995 0.993 0.987 
R2 0.925 0.992 0.986 0.974 
 
 
Fig. 3 — Results of ABTS Scavenging activity assay 
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anti-oxidant efficacy involves an electron shuttle 
enzymatic metal reduction process44. This may be 
influenced by the size and charge on the metal ion. 
The results of the anti-diabetic assays performed 
with the three NFAE-MNPs are given in Figs. 3 and 4. 
The Table 2 lists the IC50values, R and R
2 values for 
the three assays. It can be well inferred from the 
results that all the three test samples possess the 
ability to inhibit the enzymes responsible for increase 
of glucose concentration in blood plasma. These 
enzymes favour glycogenolysis and gluconeogenesis 
pathways thereby causing an increase in blood 
glucose levels. Inhibition of these enzymes can be 
considered as one of the treatments for diabetes. In 
the present study it is understood that NFAE-CuNPs 
and NFAE-AgNPs inhibit α-glycosidase and α-
amylase enzymes effectively.  
Conclusion 
The excellent anti-oxidant efficacy of the NFAE-
MNPs in scavenging DPPH, NO, ABTS and OH 
radicals along-with the anti –diabetic potential of them 
in inhibitingα-amylase , α-glucosidase and controlling 
the  glycosylation of hemoglobin has been reported. 
These nanoparticles can potentially overcome many 
constraints of small-molecule antioxidants, by 
displaying superior bio-availability, higher stability and 
the possibility to reach precise targets. 
In conclusion, these biogenic MNPs are 
dependable, efficacious, foreseeable, scalable, and 
reproducible, do not involve hazardous chemicals, 
contains the organic compounds in the plant engaged 
as capping, reducing as well as stabilizing agents. 
Therefore these are secure, convenient to be used for 
radical-scavenging, cancer treatment and glycosidase 
suppression remedies. In the present study promising 
results were obtained for NFAE-CuNPs. CuNPs, 
being more bio-compatible and not detrimental, has a 
preference over other metal nanoparticles with 
medicinal relevance45. The exact mechanism of anti-
oxidant and anti-diabetic properties exhibited by these 
metal nanoparticles need further research. 
Table 1 — Results obtained for all the four anti –oxidant assays performed for all the three NFAE-MNPs .  
IC50 , R and R
2 values are compared with the standard ascorbic acid  
Method NFAE-AgNPs NFAE-AuNPs NFAE-CuNPs Ascorbic acid 
DPPH radical scavenging assay IC50 (μg/mL) 74.19 69.77 61.9 38.99 
R 0.981 0.983 0.993 0.998
R2 0.963 0.967 0.986 0.996
NO radical scavenging assay IC50 (µg/mL) 66.87 65.57 58.52 43.50 
R 0.979 0.977 0.984 0.998
R2 0.958 0.955 0.970 0.997
ABTS radical scavenging assay IC50 (µg/mL) 58.54 60.04 52.7 46.48 
R 0.993 0.999 0.982 0.984
R2 0.986 0.997 0.965 0.968
OH radical scavenging assay IC50 (µg/mL) 55.96 57.86 51.92 48.30 
R 0.988 0.994 0.981 0.998
R2 0.976 0.987 0.963 0.996
Fig. 4 — Results of hydroxyl radical scavenging activity assay 
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